1.

In November 2020, which of the following has launched a new large-scale late-stage trial to test a two-dose regimen of its experimental COVID-19 vaccine?

A. Pfizer
B. AstraZeneca
C. Johnson & Johnson
D. Procter and Gamble
E. Gilead Sciences
Answer» D. Procter and Gamble


Discussion

No Comment Found